期刊
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
卷 45, 期 2, 页码 185-192出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2008.04.014
关键词
microRNA; mRNA; gene regulation; cardiomyopathy; adrenergic receptor
资金
- NIH [HL51239, HL048014, HL088708]
- Leducq Foundation
- University of Colorado Heart Failure and Cardiac Transplant
MicroRNAs (miRNAs) arc small, noncoding similar to 22-nucleotide regulatory RNAs that are key regulators of gene expression programs. Their role in the context of the cardiovascular system has only recently begun to be explored; however, changes in the expression of miRNAs have been associated with cardiac development and with several pathophysiological states including myocardial hypertrophy and heart failure. We demonstrate that miRNA expression patterns are distinct in two types of heart failure: idiopathic dilated cardiomyopathy and ischemic cardiomyopathy. To pursue the observation that changes in expression levels of individual miRNAs are functionally relevant, microRNA mimics and inhibitors to miR-92, miR-100 and miR-133b were expressed in primary cultures of neonatal rat cardiac myocytes. These studies demonstrated that over-expression of miR-100 is involved in the beta-adrenergic receptor-mediated repression of adult cardiac genes (i.e., alpha-myosin heavy chain, SERCA2a), and that over-expression or miR-133b prevents changes in gene expression patterns mediated by beta-adrenergic receptor stimulation. In conclusion, some miRNA expression patterns appear to be unique to the etiology of cardiomyopathy and changes in the expression level of miRs 100 and 133b contribute to regulation of the fetal gene program. It is likely that this miR-directed reprogramming of key remodeling genes is involved in the establishment and progression of common human cardiomyopathies. (C) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据